» Articles » PMID: 18596939

Aberrant Expression of Oncogenic and Tumor-suppressive MicroRNAs in Cervical Cancer is Required for Cancer Cell Growth

Overview
Journal PLoS One
Date 2008 Jul 4
PMID 18596939
Citations 341
Authors
Affiliations
Soon will be listed here.
Abstract

MicroRNAs (miRNAs) play important roles in cancer development. By cloning and sequencing of a HPV16(+) CaSki cell small RNA library, we isolated 174 miRNAs (including the novel miR-193c) which could be grouped into 46 different miRNA species, with miR-21, miR-24, miR-27a, and miR-205 being most abundant. We chose for further study 10 miRNAs according to their cloning frequency and associated their levels in 10 cervical cancer- or cervical intraepithelial neoplasia-derived cell lines. No correlation was observed between their expression with the presence or absence of an integrated or episomal HPV genome. All cell lines examined contained no detectable miR-143 and miR-145. HPV-infected cell lines expressed a different set of miRNAs when grown in organotypic raft cultured as compared to monolayer cell culture, including expression of miR-143 and miR-145. This suggests a correlation between miRNA expression and tissue differentiation. Using miRNA array analyses for age-matched normal cervix and cervical cancer tissues, in combination with northern blot verification, we identified significantly deregulated miRNAs in cervical cancer tissues, with miR-126, miR-143, and miR-145 downregulation and miR-15b, miR-16, miR-146a, and miR-155 upregulation. Functional studies showed that both miR-143 and miR-145 are suppressive to cell growth. When introduced into cell lines, miR-146a was found to promote cell proliferation. Collectively, our data indicate that downregulation of miR-143 and miR-145 and upregulation of miR-146a play a role in cervical carcinogenesis.

Citing Articles

HPV-driven oncogenesis-much more than the E6 and E7 oncoproteins.

Janiszewska J, Kostrzewska-Poczekaj M, Wierzbicka M, Brenner J, Giefing M J Appl Genet. 2024; 66(1):63-71.

PMID: 38907809 PMC: 11761861. DOI: 10.1007/s13353-024-00883-y.


The Screening of microRNAs in Chronic Myeloid Leukemia: A Clinical Evaluation.

Wosniaki D, Marin A, Oliveira R, Koerich G, Munhoz E, Farias J Int J Mol Sci. 2024; 25(6).

PMID: 38542337 PMC: 10969883. DOI: 10.3390/ijms25063363.


Absolute Quantification of Selected microRNAs Expression in Endometrial Cancer by Digital PCR.

Bogaczyk A, Potocka N, Paszek S, Skrzypa M, Zuchowska A, Kosny M Int J Mol Sci. 2024; 25(6).

PMID: 38542261 PMC: 10969921. DOI: 10.3390/ijms25063286.


Hsa-miR-194-5p and hsa-miR-195-5p are down-regulated expressed in high dysplasia HPV-positive Pap smear samples compared to normal cytology HPV-positive Pap smear samples.

Dehghani A, Khajepour F, Dehghani M, Razmara E, Zangouey M, Fekri Soofi Abadi M BMC Infect Dis. 2024; 24(1):182.

PMID: 38342922 PMC: 10860252. DOI: 10.1186/s12879-023-08942-1.


Epstein-Barr virus-encoded EBNA2 downregulates ICOSL by inducing miR-24 in B-cell lymphoma.

Leopizzi M, Mundo L, Messina E, Campolo F, Lazzi S, Angeloni A Blood. 2023; 143(5):429-443.

PMID: 37847858 PMC: 10862363. DOI: 10.1182/blood.2023021346.


References
1.
Pfeffer S, Zavolan M, Grasser F, Chien M, Russo J, Ju J . Identification of virus-encoded microRNAs. Science. 2004; 304(5671):734-6. DOI: 10.1126/science.1096781. View

2.
Fritz J, Girardin S, Philpott D . Innate immune defense through RNA interference. Sci STKE. 2006; 2006(339):pe27. DOI: 10.1126/stke.3392006pe27. View

3.
Gao X, Gulari E, Zhou X . In situ synthesis of oligonucleotide microarrays. Biopolymers. 2004; 73(5):579-96. DOI: 10.1002/bip.20005. View

4.
He L, Thomson J, Hemann M, Hernando-Monge E, Mu D, Goodson S . A microRNA polycistron as a potential human oncogene. Nature. 2005; 435(7043):828-33. PMC: 4599349. DOI: 10.1038/nature03552. View

5.
Han J, Lee Y, Yeom K, Nam J, Heo I, Rhee J . Molecular basis for the recognition of primary microRNAs by the Drosha-DGCR8 complex. Cell. 2006; 125(5):887-901. DOI: 10.1016/j.cell.2006.03.043. View